Keyphrases
Treatment Intensity
100%
Childhood Acute Lymphoblastic Leukemia
100%
Media Risk
100%
Maintenance Treatment
100%
Dexamethasone Pulse
100%
Treatment Effect
100%
Parental Functioning
100%
Standard Risk
70%
Parent Report
30%
Clinical High Risk
20%
Acute Lymphoblastic Leukemia
20%
Quality of Life
20%
Sleep Problems
20%
Clinical Distress
20%
Media Standards
20%
Dutch
10%
Risk Stratification
10%
Pediatric Patients
10%
Leukemia Patients
10%
Sleep Disturbance
10%
Regression Analysis
10%
Mental Quality of Life
10%
Life Impairments
10%
Distress Thermometer
10%
Medical Outcomes Study
10%
Child Sleep
10%
Parent Sleep
10%
Parental Distress
10%
Child Behavior
10%
Score Differences
10%
Short Form-12
10%
Prognosis Estimation
10%
Patient-completed
10%
Distress Score
10%
Psychosocial Support
10%
Treatment Burden
10%
Quality of Life Assessment
10%
Oral Chemotherapy
10%
Patient Report
10%
Sleep Quality
10%
Overall Strain
10%
Stratified Therapy
10%
Intravenous Chemotherapy
10%
Group-level Outcome
10%
Parenting Quality
10%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Dexamethasone
100%
Maintenance Therapy
100%
Pulse Rate
100%
High Risk Population
33%
Quality of Life
33%
Chemotherapy
16%
Risk Stratification
8%
Pediatrics Patient
8%
Psychosocial Care
8%
Population
8%
Sleep Studies
8%
Sleep Disorder
8%
Short Form 12
8%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
100%
Dexamethasone
100%
Maintenance Therapy
100%
Pulse Rate
100%
Quality of Life
33%
High Risk Population
33%
Reference Value
16%
Sleep Disorder
8%
Population
8%
Pediatrics Patient
8%
Short Form 12
8%
Psychosocial Care
8%
Biochemistry, Genetics and Molecular Biology
Pulse Rate
100%
Dexamethasone
100%
High Risk Population
33%
Reference Value
16%
Population
8%
Sleep Studies
8%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamethasone
100%
Acute Lymphoblastic Leukemia
100%
Chemotherapy
16%
Sleep Disorder
8%
Sleep Studies
8%
Neuroscience
Dexamethasone
100%
Behavior (Neuroscience)
8%
Sleep Disorder
8%
Sleep Studies
8%